Your browser doesn't support javascript.
loading
An anti-ErbB2 fully human antibody circumvents trastuzumab resistance.
Lu, Qiong; Wang, Lingfei; Zhang, Yajun; Yu, Xiaojie; Wang, Chao; Wang, Huajing; Yang, Yang; Chong, Xiaodan; Xia, Tian; Meng, Yanchun; Wang, Yuxiao; Lu, Cuihua; Zhou, Lijun; Li, Bohua.
Afiliación
  • Lu Q; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Wang L; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Zhang Y; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Yu X; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Wang C; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Wang H; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Yang Y; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Chong X; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Xia T; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
  • Meng Y; School of Medicine, Nankai University, Tianjin, People's Republic of China.
  • Wang Y; Central Laboratory, Navy General Hospital, Beijing People's Republic of China.
  • Lu C; Department of Gastroenterology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
  • Zhou L; Central Laboratory, Navy General Hospital, Beijing People's Republic of China.
  • Li B; International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
Oncotarget ; 7(41): 67129-67141, 2016 10 11.
Article en En | MEDLINE | ID: mdl-27564098
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Resistencia a Antineoplásicos / Anticuerpos Monoclonales / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Resistencia a Antineoplásicos / Anticuerpos Monoclonales / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos